Chronic inhibition of PPAR-γ signaling induces endothelial dysfunction in the juvenile lamb

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 2, 2013, Pages 271-280

  Sharma, Shruti ^a   Barton, Jubilee ^b   Rafikov, Ruslan ^a   Aggarwal, Saurabh ^a   Kuo, Hsuan Chang ^b   Oishi, Peter E ^b,c   Datar, Sanjeev A ^b   Fineman, Jeffrey R ^b,c   Black, Stephen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carnitine metabolism; Mitochondrial dysfunction; NO signaling; Oxidative stress

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ACETYLCHOLINE; CARNITINE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; GUANYLATE CYCLASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXYNITRITE; PHOSPHODIESTERASE V;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HOMEOSTASIS; IMMUNOPRECIPITATION; INHIBITION KINETICS; JUVENILE ANIMAL; LAMB; LUNG BLOOD FLOW; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASODILATATION;

AGING; ANILIDES; ANIMALS; CARNITINE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; ENDOTHELIUM, VASCULAR; HSP90 HEAT-SHOCK PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; PPAR GAMMA; SHEEP; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 84874558989     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.12.004     Document Type: Article

References (44)

1. Rabinovitch M., Bothwell T., Hayakawa B.N., Williams W.G., Trusler G.A., Rowe R.D., et al. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest 1986, 55:632-653.
2. Celermajer D.S., Cullen S., Deanfield J.E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993, 87:440-446.
3. Yoshibayashi M., Nishioka K., Nakao K., Saito Y., Matsumura M., Ueda T., et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991, 84:2280-2285.
4. Fratz S., Fineman J.R., Gorlach A., Sharma S., Oishi P., Schreiber C., et al. Early determinants of pulmonary vascular remodeling in animal models of complex congenital heart disease. Circulation 2011, 123:916-923.
5. Tian J., Smith A., Nechtman J., Podolsky R., Aggarwal S., Snead C., et al. Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension. Physiol Genomics 2009, 40:48-60.
6. Nisbet R.E., Sutliff R.L., Hart C.M. The role of peroxisome proliferator-activated receptors in pulmonary vascular disease. PPAR Res 2007 2007, 18797.
7. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature 2000, 405:421-424.
8. Vamecq J., Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999, 354:141-148.
9. Nicol C.J., Adachi M., Akiyama T.E., Gonzalez F.J. PPARgamma in endothelial cells influences high fat diet-induced hypertension. Am J Hypertens 2005, 18:549-556.
10. Guignabert C., Alvira C.M., Alastalo T.P., Sawada H., Hansmann G., Zhao M., et al. Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol 2009, 297:L1082-L1090.
11. Ameshima S., Golpon H., Cool C.D., Chan D., Vandivier R.W., Gardai S.J., et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 2003, 92:1162-1169.
12. Sutliff RL, Kang BY, Hart CM. PPARgamma as a potential therapeutic target in pulmonary hypertension. Ther Adv Respir Dis, 4:143-60.
13. Sharma S., Sud N., Wiseman D.A., Carter A.L., Kumar S., Hou Y., et al. Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008, 294:L46-L56.
14. Aggarwal S., Gross C.M., Kumar S., Datar S., Oishi P., Kalka G., et al. Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration. J Cell Physiol 2011.
15. Black S.M., Fineman J.R., Steinhorn R.H., Bristow J., Soifer S.J. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 1998, 275:H1643-H1651.
16. Reddy V.M., Wong J., Liddicoat J.R., Johengen M., Chang R., Fineman J.R. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 1996, 271:H562-H570.
17. Denninger J.W., Marletta M.A. Guanylate cyclase and the.NO/cGMP signaling pathway. Biochim Biophys Acta 1999, 1411:334-350.
18. Evora P.R., Evora P.M., Celotto A.C., Rodrigues A.J., Joviliano E.E. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Curr Drug Targets 2012, 13:1207-1214.
19. Sud N., Sharma S., Wiseman D.A., Harmon C., Kumar S., Venema R.C., et al. Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1444-L1453.
20. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
21. Blanquart C., Barbier O., Fruchart J.C., Staels B., Glineur C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 2003, 85:267-273.
22. Denning G.M., Stoll L.L. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?. Pediatr Pulmonol 2005.
23. Oishi P., Sharma S., Datar S., Kumar S., Raff G., Azakie A., et al. Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow. Pediatr Res 2012, [Epub ahead of print].
24. Tschudi M.R., Mesaros S., Lüscher T.F., Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 1996, 27:32-35.
25. Nisbet RE, Bland JM, Kleinhenz DJ, Mitchell PO, Walp ER, Sutliff RL, et al. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol,42:482-90.
26. Hansmann G., de Jesus Perez V.A., Alastalo T.P., Alvira C.M., Guignabert C., Bekker J.M., et al. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 2008, 118:1846-1857.
27. Aggarwal S., Rafikov R., Gross C.M., Kumar S., Pardo D., Black S.M. Purification and functional analysis of protein kinase G-1alpha using a bacterial expression system. Protein Expr Purif 2011.
28. Burgoyne J.R., Madhani M., Cuello F., Charles R.L., Brennan J.P., Schroder E., et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317:1393-1397.
29. Zhao Y.Y., Zhao Y.D., Mirza M.K., Huang J.H., Potula H.H., Vogel S.M., et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 2009, 119:2009-2018.
30. Oishi P., Sharma S., Grobe A., Azakie A., Harmon C., Johengen M.J., et al. Alterations in cGMP, soluble guanylate cyclase, phosphodiesterase 5, and B-type natriuretic peptide induced by chronic increased pulmonary blood flow in lambs. Pediatr Pulmonol 2007, 42:1057-1071.
31. Black S.M., Sanchez L.S., Mata-Greenwood E., Bekker J.M., Steinhorn R.H., Fineman J.R. sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1051-L1057.
32. Grobe A.C., Wells S.M., Benavidez E., Oishi P., Azakie A., Fineman J.R., et al. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1069-L1077.
33. Sharma S., Kumar S., Wiseman D.A., Kallarackal S., Ponnala S., Elgaish M., et al. Perinatal changes in superoxide generation in the ovine lung: alterations associated with increased pulmonary blood flow. Vasc Pharmacol 2010, 53:38-52.
34. Tian J., Fratz S., Hou Y., Lu Q., Gorlach A., Hess J., et al. Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease. Physiol Genomics 2011, 43:87-98.
35. Ovadia B., Reinhartz O., Fitzgerald R., Bekker J.M., Johengen M.J., Azakie A., et al. Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 2003, 284:H480-H490.
36. Oishi P.E., Wiseman D.A., Sharma S., Kumar S., Hou Y., Datar S.A., et al. Progressive dysfunction of nitric oxide synthase in a lamb model of chronically increased pulmonary blood flow: a role for oxidative stress. Am J Physiol Lung Cell Mol Physiol 2008, 295:L756-L766.
37. Xu H., Shi Y., Wang J., Jones D., Weilrauch D., Ying R., et al. A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function. J Biol Chem 2007, 282:37567-37574.
38. Kerner J., Hoppel C. Fatty acid import into mitochondria. Biochim Biophys Acta 2000, 1486:1-17.
39. Vaz F.M., Wanders R.J. Carnitine biosynthesis in mammals. Biochem J 2002, 361:417-429.
40. Liu J., Atamna H., Kuratsune H., Ames B.N. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci 2002, 959:133-166.
41. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A 2002, 99:2356-2361.
42. Liu J., Killilea D.W., Ames B.N. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A 2002, 99:1876-1881.
43. Sharma S., Sun X., Rafikov R., Kumar S., Hou Y., Oishi P.E., et al. PPAR-gamma regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flow. PLoS One 2012, 7:e41555.
44. Mascaro C., Acosta E., Ortiz J.A., Marrero P.F., Hegardt F.G., Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 1998, 273:8560-8563.